Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neurometrix (DE:NLZ)
FRANKFURT:NLZ
Neurometrix (NLZ) Stock Price & Analysis
0 Followers
NLZ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.12 - €1.79
Previous Close€0.14
Volume0.00
Average Volume (3M)N/A
Market Cap
€3.95M
Enterprise Value-€11.90M
Total Cash (Recent Filing)$17.64M
Total Debt (Recent Filing)$271.26K
Price to Earnings (P/E)―
Beta-0.49
Next Earnings
Jan 25, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding8,591,374
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.22
Price to Sales (P/S)1.05
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-2.60
Enterprise Value/Gross Profit-2.07
Enterprise Value/Ebitda-8.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Neurometrix News
PremiumPress Releases
NeuroMetrix Reports Q3 2023 Business Highlights
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
NLZ FAQ
What was Neurometrix’s price range in the past 12 months?
Neurometrix lowest stock price was €0.12 and its highest was €1.79 in the past 12 months.
What is Neurometrix’s market cap?
Currently, no data Available
When is Neurometrix’s upcoming earnings report date?
Neurometrix’s upcoming earnings report date is Jan 25, 2024 which is 161 days ago.
How were Neurometrix’s earnings last quarter?
Neurometrix released its earnings results on Oct 26, 2023. The company reported -€0.19 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.19.
Is Neurometrix overvalued?
According to Wall Street analysts Neurometrix’s price is currently Overvalued.
Does Neurometrix pay dividends?
Neurometrix does not currently pay dividends.
What is Neurometrix’s EPS estimate?
Neurometrix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neurometrix have?
Currently, no data Available
What happened to Neurometrix’s price movement after its last earnings report?
Neurometrix reported an EPS of -€0.19 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3%.
Which hedge fund is a major shareholder of Neurometrix?
Currently, no hedge funds are holding shares in DE:NLZ
---
Neurometrix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.53%
12-Months-Change
Fundamentals
Return on Equity
-26.61%
Trailing 12-Months
Asset Growth
-11.42%
Trailing 12-Months
Company Description
Neurometrix
NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.
---
Technical Analysis
---